アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

Patents, Articles & Conferences

  • Home
  • News
  • Patents, Articles & Conferences

We will be presenting our Dry eye project results at ARVO 2024 (May 5th – 9th at Seattle)

ARVO2024
May 5th-9th 2024 / The Seattle Convention Center, Seattle, Wash
Session Date / Time : May 9th 2024 / 8:00 AM to 9:45 AM
Poster Session 506, Session Title: Dry eye; non clinical
Posterboard Number: 5768 – B0332

Dr Chizuko Koseki (President & CEO, TAGCyx Biotechnologies, Inc, Meguro, Tokyo, Japan)
TITLE: Effect of Topical Administration of Novel anti-Interferon-Gamma Aptamer in severe Murine Dry Eye model